Mateo J, de Bono JS, Fizazi K, Saad F, et al. Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial. J Clin Oncol 2023 Nov 14:JCO2300339. doi: 10.1200/JCO.23.00339.
PMID: 37963304